ค่าใช้จ่ายที่ประหยัดได้จากการให้ข้อมูลขนาดยาที่เหมาะสมในผู้ป่วยที่มีการทำงานของไตบกพร

•

0 likes•1,141 views

Rachanont Hiranwong

นำเสนอผลงานวิจัยเรื่องค่าใช้จ่ายที่ประหยัดได้จากการให้ข้อมูลขนาดยาที่เหมาะสมในผู้ป่วยที่มีการทำงานของไตบกพร่อง

 MITNET
Cockcroft and Gault


doctor order sheet



= –
Amoxicillin/Clavulanate
injection G IV q 8 hr G IV q 12 hr
x 3) -
28.25 x 2] x 7 = 28.25 x 7 = 197.75

Amikacin 500 mg IV q 24 hr
x 2 = 64.2
Off

Photo by Ary - In the Nature with my Canon (https://www.flickr.com/photos/arybrami/)

โปสเตอร์เรื่อง "ค่าใช้จ่ายที่ประหยัดได้จากการให้ข้อมูลขนาดยาที่เหมาะสมในผู้ป่วยที่มีการทำงานของไตบกพร่อง" นำเสนอที่การประชุมวิชาการแลกเปลี่ยนเรียนรู้ ด้านการพัฒนาระบบบริการ จังหวัดชลบุรี ประจำปี ๒๕๕๘

การดูแลการใช้ยาในผู้ป่วยโรคตับ

Rachanont Hiranwong

Pharmcare in TB/HIV patient

Rachanont Hiranwong

RDU in Banglamung Hospital

Rachanont Hiranwong

เอกสารประกอบการสอนวิชาเภสัชบำบัด ๓ (๗๙๑๕๕๑) หัวข้อ Assessment of Adverse drug...

Rachanont Hiranwong

เอกสารประกอบการสอนวิชาเภสัชบำบัด ๓ (๗๙๑๕๕๑) หัวข้อ Assessment of Adverse drug reaction สำหรับนิสิตเภสัชศาสตร์ มหาวิทยาลัยบูรพา ชั้นปีที่ ๕ ภาคเรียนที่ ๑/๒๕๕๙ บรรยายและปฏิบัติการ: วันศุกร์ที่ ๑๖ กันยายน ๒๕๕๙ เวลา ๐๙.๐๐-๑๒.๐๐ น. ณ ห้อง PH402 อาคารปฏิบัติการเภสัชกรรมชุมชนและห้องปฏิบัติการผลิตยา

การพัฒนาระบบติดตามและให้ข้อมูลขนาดยาในผู้ป่วยในที่มีการทำงานของไตลดลงRenal do...

Rachanont Hiranwong

การพัฒนาระบบติดตามและให้ข้อมูลขนาดยาในผู้ป่วยในที่มีการทำงานของไตลดลง นำเสนอที่ การประชุมวิชาการ 14th HA National Forum “องค์กรที่น่าไว้วำงใจ” (High Reliability Organization)

การพัฒนาระบบติดตามและให้ข้อมูลขนาดยาในผู้ป่วยในที่มีการทำงานของไตลดลง นำเสนอที่ งานประชุมวิชาการสำนักงานสาธารณสุขจังหวัดชลบุรี ประจำปี 2555 โดย สำนักงานสาธารณสุขจังหวัดชลบุรี

การเฝ้าระวังผลต่อไตจากการใช้ยาเทโนโฟเวียร์ในผู้ป่วยติดเชื้อเอชไอวีโรงพยาบาลบา...

Rachanont Hiranwong

การเฝ้าระวังผลต่อไตจากการใช้ยาเทโนโฟเวียร์ในผู้ป่วยติดเชื้อเอชไอวีโรงพยาบาลบางละมุง นำเสนอที่การประชุมวิชาการงานเฝ้าระวังความปลอดภัยจากการใช้ยา ประจำปี 2554 โดย สำนักงานคณะกรรมการอาหารและยา

การพัฒนาระบบยา 2558

Rachanont Hiranwong

ระบบยาและงานบริบาลเภสัชกรรม

Rachanont Hiranwong

หลักเกณฑ์ และแนวทาง การเปิดเผยราคากลางของหน่วยงานRachanont Hiranwong

Rachanont Hiranwong

การเฝ้าระวังผลต่อไตจากการใช้ยาเทโนโฟเวียร์ในผู้ป่วยติดเชื้อเอชไอวีโรงพยาบาลบางละมุง, ข่าวสารด้านยาและผลิตภัณฑ์สุขภาพ ศูนย์เฝ้าระวังความปลอดภัยด้านผลิตภัณฑ์สุขภาพ ปีที่ 15 ฉบับที่ 4 ตุลาคม – ธันวาคม 2555, น. 117 – 123.

ระบบยา

Rachanont Hiranwong

การเฝ้าระวังผลต่อไตจากการใช้ยาเทโนโฟเวียร์ในผู้ป่วยติดเชื้อเอชไอวีโรงพยาบาลบ...Rachanont Hiranwong

การพัฒนาระบบติดตามและให้ข้อมูลขนาดยาในผู้ป่วยในที่มีการทำงานของไตลดลง Rachanont Hiranwong

นำเสนอการพัฒนาระบบติดตามและให้ข้อมูลขนาดRachanont Hiranwong

ยาเข้าใหม่ 2555Rachanont Hiranwong

Adr assessment and monitoring

Rachanont Hiranwong

Medication reconciliation slide

Rachanont Hiranwong

การจัดการผู้ป่วยแจ้งประวัติแพ้ยา

Rachanont Hiranwong

Adverse drug reaction 09

Rachanont Hiranwong

การให้บัตรแพ้ยา

Rachanont Hiranwong

การเตรียมน้ำเกลือที่มีความเข้มข้นแตกต่างจากที่มีในบัญชีโรงพยาบาลRachanont Hiranwong

Integrated pharmaceutical careRachanont Hiranwong

Eye medication slide

Rachanont Hiranwong

Acutecare(webversion)

Rachanont Hiranwong

BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx

AnushriSrivastav

Defecation Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool. Normal defecation is painless, resulting in passage of soft, formed stool CONSTIPATION Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces IMPACTION Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon. DIARRHEA Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration HEMORRHOIDS Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal. FLATULENCE As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus) FECAL INCONTINENCE Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY, An enema is the instillation of a solution into the rectum and sig

CANCER CANCER CANCER CANCER CANCER CANCER

KRISTELLEGAMBOA2

Recently uploaded

BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx

AnushriSrivastav

CANCER CANCER CANCER CANCER CANCER CANCER

KRISTELLEGAMBOA2

Introduction to Forensic Pathology course

fprxsqvnz5

CONSTRUCTION OF TEST IN MANAGEMENT .docx

PGIMS Rohtak

Health Education on prevention of hypertension

Radhika kulvi

Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The

Myopia Management & Control Strategies.pptx

RitonDeb1

Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond

Health Catalyst

Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs). In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.

Navigating Healthcare with Telemedicine

Iris Thiele Isip-Tan

CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf

Sachin Sharma

This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.

The Docs PPG - 30.05.2024.pptx..........

TheDocs

Navigating Women's Health: Understanding Prenatal Care and Beyond

Aboud Health Group

Navigating Challenges: Mental Health, Legislation, and the Prison System in B...

Guillermo Rivera

This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.

Dimensions of Healthcare Quality

Naeemshahzad51

The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.

Yemen National Tuberculosis Program .ppt

Esam43

How many patients does case series should have In comparison to case reports.pdf

pubrica101

Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop. https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/

Essential Metrics for Palliative Care Management

Care Coordinations

Explore our infographic on 'Essential Metrics for Palliative Care Management' which highlights key performance indicators crucial for enhancing the quality and efficiency of palliative care services. This visual guide breaks down important metrics across four categories: Patient-Centered Metrics, Care Efficiency Metrics, Quality of Life Metrics, and Staff Metrics. Each section is designed to help healthcare professionals monitor and improve care delivery for patients facing serious illnesses. Understand how to implement these metrics in your palliative care practices for better outcomes and higher satisfaction levels.

Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...

Dr. David Greene Arizona

Medical Technology Tackles New Health Care Demand - Research Report - March 2...

pchutichetpong

M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028. According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.” There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation. The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs. In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.

Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...

ILC- UK

The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer. Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer. The speakers included: Professor Orazio Schillaci, Minister of Health, Italy Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden

India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...

Kumar Satyam

According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market. Growing Prevalence of Lifestyle Diseases The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.

Recently uploaded (20)

BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx

CANCER CANCER CANCER CANCER CANCER CANCER

Introduction to Forensic Pathology course

CONSTRUCTION OF TEST IN MANAGEMENT .docx

Health Education on prevention of hypertension

Myopia Management & Control Strategies.pptx

Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond

Navigating Healthcare with Telemedicine

CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf

The Docs PPG - 30.05.2024.pptx..........

Navigating Women's Health: Understanding Prenatal Care and Beyond

Navigating Challenges: Mental Health, Legislation, and the Prison System in B...

Dimensions of Healthcare Quality

Yemen National Tuberculosis Program .ppt

How many patients does case series should have In comparison to case reports.pdf

Essential Metrics for Palliative Care Management

Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...

Medical Technology Tackles New Health Care Demand - Research Report - March 2...

Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...

India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...